Bio Chem Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 3.88 M
- Revenue Growth 24.00%
- Profit Growth 2356.00%
- Ebitda -13.21%
- Net Worth 34.85%
- Total Assets 16.27%
About Bio Chem Diagnostics
Bio Chem Diagnostics Private Limited (BCDPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2010 and has a history of 14 years and ten months. Its registered office is in Mysore, Karnataka.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.88 M.
Elizabeth Frank and Muddappa Konganda serve as directors at the Company.
Company Details
- LocationMysore, Karnataka
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85196KA2010PTC052998
- Company No.
052998
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2010
- Date of AGM
27 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Bio Chem Diagnostics?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Muddappa Konganda | Managing Director | 26-Mar-2010 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Elizabeth Frank | Director | 26-Mar-2010 | Current |
Financial Performance of Bio Chem Diagnostics.
Bio Chem Diagnostics Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 24% increase. The company also saw a substantial improvement in profitability, with a 2356% increase in profit. The company's net worth Soared by an impressive increase of 34.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Chem Diagnostics?
In 2017, Bio Chem Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.88 M
₹0
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 0.29 Cr
- State Bank Of India : 0.10 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
10 Aug 2012 | The South Indian Bank Limited | ₹2.88 M | Open |
28 Mar 2011 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Bio Chem Diagnostics?
Unlock and access historical data on people associated with Bio Chem Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Chem Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Chem Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.